sb 203580 has been researched along with ic 87114 in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ic 87114) | Trials (ic 87114) | Recent Studies (post-2010) (ic 87114) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 70 | 0 | 48 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Abdel-Tawab, H; Ahmed, EA; Alhazza, IM; Badr, G; Hassan, K; Saad, H; Waly, H | 1 |
2 other study(ies) available for sb 203580 and ic 87114
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Type I interferon (IFN-alpha/beta) rescues B-lymphocytes from apoptosis via PI3Kdelta/Akt, Rho-A, NFkappaB and Bcl-2/Bcl(XL).
Topics: Adenine; Amides; Animals; Antibodies, Blocking; Apoptosis; B-Lymphocytes; bcl-X Protein; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Gene Expression Regulation; Humans; Imidazoles; Immunologic Memory; Interferon Type I; Lymphocyte Subsets; Mice; NF-kappa B; Oncogene Protein v-akt; Peptides; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyridines; Quinazolines; Receptors, Interferon; Recombinant Proteins; rho-Associated Kinases; Signal Transduction | 2010 |